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ABSTRACT: A new and flexible approach toward the synthesis of 6,12-guaianolide anticancer drugs such as trilobolides or 
thapsigargin is developed, which could be applied to the preparation of analogues with a modified ring system. The synthesis starts 
from commercial 2-methyl-cyclopentane-1,3-dione, only relying on diastereoselective reactions for the construction of the stereo-
genic centers at C1, C3, C6 and C10 and features a high-yielding ring-closing enyne metathesis (RCEYM) step for the formation of 
the [5,7] bicyclic core. 
Cancer is still a major health issue and solutions for all 
facets of this problem include the continuous search for 
new active molecules. Among them, thapsigargin 1a 
(Tg, Figure 1),1 emerged during the last decade as a 
highly promising anticancer lead compound, and pro-
drug derivatives of 1a are currently in phase II clinical 
trials directed toward a variety of cancers such as pros-
tate cancer or hepatocellular carcinoma, as well as neo-
vascular tissues in a broad range of other cancer cells.2 
This plant secondary metabolite, as well as its structural-
ly closely related 2-deoxy natural congeners trilobolides 
1b, 1c3 or thapsivillosin F 1d,4 belong to the class of the 
6,12-guaianolide sesquiterpenes5 known for their promi-
nent endo/sarcoplasmic calcium ATPase (SERCA) in-
hibitor activities.6  
To date, three total syntheses of this class of guaiano-
lides were reported with more than a 13-year gap be-
tween the first synthesis and the two most recent ones. 
The pioneering work of Ley’s group in 2003 was based 
on a Favorskii rearrangement of a carvone-derived cy-
clohexanone precursor for the elaboration of the polyhy-
droazulene scaffold of the molecule, followed by exten-
sive functional transformations.7 
 
Figure 1. Thapsigargin and trilobolides 
Two additional total syntheses appeared very recently.8 
Baran's group published a concise route featuring a clas-
sical photochemical rearrangement of a santonin-type 
intermediate obtained from dihydrocarvone. Subsequent 
adequate functionalizations led to 1a.8a Evans and co-
wokers assembled the bicylic core of thapsigargin in a 
very efficient fashion using an intramolecular pinacol 
coupling.8b Other partial approaches of the polyhydro-
azulene skeleton of these molecules have been also pub-
lished.9  
In our laboratories, due to the high pharmacological 
potential of thapsigargin and the continuing scientific 
impetus to understand more fully and/or modulate the 
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 interaction of this family of molecules with therapeuti-
cally significant SERCA targets, it was decided that we 
would develop synthetic strategies able to deliver “upon 
request” the natural molecules, as well as unnatural 
skeleton-modified analogues. To be practical, the devel-
oped routes have to require only incremental modifica-
tions from the initially developed synthetic route.  
In an integrated program devoted to the synthesis of 
thapsigargin family 1 itself as well as targeted analogues 
possessing a modified framework, an allene-yne Pauson-
Khand double annulation reaction was employed for an 
asymmetric synthesis of a complex system related to 
thapsigargin.10 More recently, application of this ap-
proach for the synthesis of functionalized guaiane-type 
skeletons, as well as several heterobicyclo[5.3.0] 
frameworks has been reported.11 
A second synthetic approach is also currently being 
developed in our laboratories, where the functionalized 
octahydroazulene precursor of thapsigargin is designed 
to be built from a conveniently-ramified cyclopentenol 
precursor of type 4 (n1 = 1) using a ring-closing enyne 
metathesis (RCEYM) as the key step12 to form bicycle  
3, according to the strategy depicted in Scheme 1.13 
Besides synthesizing Tg-type guaianolides with the 
natural 5-7-5 core, the embraced project will also in-
volve access to homologated analogues 2 characterized 
by 5-8-5, 5-7-6, or even 5-8-6 modified frameworks. It 
is interesting to note that, for access to these analogues, 
the RCEYM synthetic route described in the present 
paper and the previously described allene-yne Pauson-
Khand are quite complementary. For example, in the 
RCEYM case, 5-8-5 tricyclic analogues could be direct-
ly accessible using the homologated enyne 4 (n1 = 2) as 
a precursor. 
Scheme 1. Retrosynthesis for Tg family of guaianolides and 
analogues 
 
As a key strategic sequence for the viability of the ap-
proach in the case of thapsigargin and other guaiano-
lides, two successive diastereoselective additions, an 
allylation at C10,14 then an alkynylation reaction at C6, 
are envisioned to prepare 4 (n1 = 1) from the cyanocy-
clopentenyl methyl ketone 5. For the construction of the 
latter, we planned a sequence similar to that used by 
Ciufolini et al. for the synthesis of sordarin,15 i.e., se-
quential condensation of Mander’s cyanoformate16 for 
the carboxylation of 2-methyl-1,3-cyclopentanedione 7, 
and cyanation with Nagata’s diethylaluminum cyanide17 
to obtain 5. We report here the results of our efforts for 
this project. 
It is worth noting that the choice of the above route to 4 
was dictated by the low overall yield of the preceding 
route based on a Michael/Wittig one-pot sequence for 
the construction of the required di-substituted cyclopen-
tene precursor 10, as summarized in Scheme 2.18 Alt-
hough large scale one-pot condensation of di-tert-butyl 
acetylenedicarboxylate 8 and 2,3-butanedione (large 
excess) led to di-tert-butyl ester 9 in 63% after optimiza-
tion, we were nevertheless unable to obtain the di-
substituted cyclopentenol ketoester 10 required for con-
tinuation of the synthesis in an acceptable yield. 
Scheme 2. Previous Michael-Wittig approach18 
 
Our first objective was the synthesis of the (±)-cis hy-
droxy methyl ketone 5 from commercial diketone 7 
(Scheme 3). Condensation of Mander’s reagent on the 
extended enolate derived from enol ether 11 using 
LiHMDS yielded 6 in 71% yield; this yield could be 
improved to 86% by using methyl chloroformate. No O-
acylation was observed with the latter reagent, presuma-
bly due to the hard nature of the enolate. Compound 6 
was subsequently submitted to the conjugate addition of 
cyanide using the Nagata reagent.  
Scheme 3. Synthesis of methyl ketone 5 
 
The resulting ketone 12 was reduced with sodium boro-
hydride at –78 °C, giving a 4:1 inseparable mixture of 
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 1,3-cis/1,3-trans alcohols 13.14 Further transformation 
into Weinreb amide 1418 gave, after chromatography, the 
required pure 1,3-cis isomer, which was converted into 
1,3-cis methyl ketone 5 upon addition of MeMgBr. This 
ketone was prone to epimerization in contact with silica 
gel, so it was carried on to the next step without purifica-
tion. 
With this ketone in hand, we next addressed the two 
important stereoselective addition reactions to set up the 
stereogenic centers at C6 and C10. For the allylation of 
methyl ketone 5,19 we hypothesised that a bridge chelate 
between the secondary hydroxyl and the methyl ketone 
would promote a stereoselective addition at C10 
(Scheme 4).20 A preliminary study for this step was car-
ried out using the methyl ester 10 synthesized in the 
previous approach. First attempts with 2 equiv of al-
lylmagnesium bromide led to a complex mixture of 
compounds, so we turned to milder nucleophiles. After 
some efforts, the best result was obtained by adding a 
large excess of allylzinc chloride formed in situ by add-
ing a stoichiometric amount of dry ZnCl2 to a solution of 
allylmagnesium bromide. Under these conditions, a 
single adduct was formed in good yield, and X-ray anal-
ysis of the derived p-nitrobenzoate21 showed that it was 
the desired diastereomer 15 (Scheme 4). This result is in 
agreement with a remote chelate TS, as depicted. Unfor-
tunately, when these conditions were applied to the cor-
responding cyanomethyl ketone 5, an almost 1:1 ratio of 
isomers was obtained. When performing the allylation 
reaction at room temperature, the ratio increased to 
80:20. This trend could reflect temperature-dependent 
aggregation forms of the mixed magnesium-zinc metal 
reacting species that can interact with the cyano-
containing substrate,22a or could be due  
Scheme 4. Stereoselective allylation reactions 
 
to the reversibility of the addition of allylzinc reagent to 
ketones.22b However, the best result was obtained with 
the corresponding allylcerium derivative, and alcohol 16 
was obtained in 85:15 dr and 87% yield (over two steps) 
from Weinreb amide 14. 
The diastereomers were successfully separated by care-
ful chromatography after protection of the secondary 
hydroxyl at C3 by a TBS group (Scheme 5). Further 
protection of the tertiary OH at C10 as a TES ether, 
followed by reduction of the cyano function by DIBAL-
H at –78 °C afforded aldehyde 17, which was then sub-
mitted to the alkynylation reaction with methyl propio-
late.23 This reaction proved to be somewhat capricious 
and was first carried out using an external trap of the 
generated alkoxide with an electrophile to get a good 
yield. Quench with TMSCl gave the persilylated ether 
18 in quantitative yield, while the acetylated analogue 
19 was obtained in 74% yield. Direct hydrolysis of the 
condensation reaction mixture failed to give the corre-
sponding alcohol 20 in reproducible yields. However, 
when this reaction was carried out in the presence of dry 
CeCl3,24 the free alcohol 20 was isolated in 81% yield. 
One explanation for the improvement in the presence of 
CeCl3 could be the formation of a more stable cerium 
alkoxide species, allowing a milder hydrolysis process 
(complexation of this alkoxide with the oxygen of the 
C10 TES ether is possible).25 Under all conditions test-
ed, a single diastereomer was obtained at C6.  
Scheme 5. Synthesis of the precursors of RCEYM 
 
Unfortunately, all attempts to obtain a crystalline deriva-
tive failed, either at this level, or after performing the 
RCEYM annelation. Since NMR experiments were also 
inconclusive, even on the bicyclic adducts, we decided 
to prepare the epimer of 20 at C-6 to compare the data in 
both series. It is worth noting that from a synthetic point 
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 of view, the use of an epimer of natural Tg at C-6 as an 
intermediate could prove useful if the formation of the -
lactone ring was performed by a Mitsunobu reaction.26 
Therefore, transformation of 20 into epi-21 was carried 
out (Scheme 5), at first with p-NO2-benzoic acid, but the 
yield was very low, due to the formation of secondary 
products resulting from, inter alia, SN2’ reactions at C4. 
Conducting the reaction in the presence of benzoic acid 
in toluene resulted in a clean reaction, giving epi-22 as a 
single adduct. 
The excellent diastereoselectivity observed for the al-
kynylation reaction is likely to result from: 1) an ap-
proach of the nucleophile from the less hindered convex 
face of 17, and 2) a reacting conformation of the alde-
hyde being s-cis, as depicted on Figure 2. This confor-
mation, and not the more stable s-trans one, is thought to 
be the reactive one due to a more favorable TS for the 
carbonyl addition reaction, in a manner similar to that 
calculated from FMO calculations by Houk et al. in the 
case of the addition of cyanide to acrolein.27 The al-
kynylation reaction of 17 would therefore probably pro-
ceed in accordance to the Curtin-Hammett principle. 
However, a more in-depth study of the two possible 
transitions states is required to clarify this question. 
 
Figure 2. Chem3D minimizations (MM2) for the s-cis and s-trans 
aldehyde 17 
We next turned to the ring-closing enyne metathesis 
reaction.28 A first set of assays established that the best 
precatalyst for the annelation reaction was Grubbs II, 
while maintaining the reaction under an ethylene atmos-
phere.29 Under these conditions at 80 °C in toluene, the 
protected enynes 18 and 19 cyclized cleanly to give the 
desired octahydroazulene adducts 23 and 24 in quantita-
tive yield (Scheme 6). These adducts correspond to the 
exo adducts expected for a seven-membered ring for-
mation by RCEYM. The unprotected precursor 20 also 
cyclized under the same conditions, although the reac-
tion was not as clean, giving variable non-identified 
minor compounds in addition to the expected adduct 25 
(68% yield).  
 
Scheme 6. RCEYM annelation 
 
The C6 Mitsunobu-epimerized enyne epi-22 was also 
submitted to RCEYM conditions. In this case, total con-
version occurred at 80 °C in shorter reaction times than 
previously. At this level, unequivocal assignment of the 
configuration at C6 was made by comparing 1H NMR 
data of epi-26 with those of compound 26, obtained by a 
RCEYM reaction of benzoate 22, readily prepared from 
20. A strong nOe interaction between H-1 and H-6 al-
lowed unambiguous assignment of the configuration at 
C-6 of epi-26 as the ”unnatural” epimer, as depicted (see 
Supporting Information for NOESY experiments).  
In conclusion, an advanced intermediate (23) of 
thapsigargin and other guaianolides has been synthe-
sized in 12 steps and 31% overall yield. The key step is 
an efficient RCEYM reaction that forms the 5,7 ring 
system in quantitative yield. Further work for the enan-
tioselective synthesis of this intermediate is in progress, 
as well as the construction of analogues with a novel 5,8 
core. Functionalization of both 23 and epi-26 toward 
guaianolides will be explored. 
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